CFAP36
gene geneOn this page
Also known as MGC15407BARTL1
Summary
CFAP36 (cilia and flagella associated protein 36, HGNC:30540) is a protein-coding gene on chromosome 2p16.1, encoding Cilia- and flagella-associated protein 36 (Q96G28). May act as an effector for ARL3.
Located in ciliary transition zone.
Source: NCBI Gene 112942 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total
- GTEx eGene: eQTL in 14 tissues, sQTL in 6 (q < 0.05)
- Constraint (gnomAD): pLI 0.01 (LoF-tolerant), LOEUF 0.87 (unconstrained)
- MANE Select transcript:
NM_080667 - Notable: 65 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30540 |
| Approved symbol | CFAP36 |
| Name | cilia and flagella associated protein 36 |
| Location | 2p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC15407, BARTL1 |
| Ensembl gene | ENSG00000163001 |
| Ensembl biotype | protein_coding |
| Entrez | 112942 |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 21 protein_coding, 10 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
MANE Select: ENST00000349456
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 3, TSL 2: 2, TSL 3: 1, TSL 5: 1
ENST00000349456, ENST00000339012, ENST00000403007, ENST00000406691, ENST00000407816, ENST00000481791, ENST00000490934, ENST00000904948, ENST00000904949, ENST00000904950, ENST00000904951, ENST00000904952, ENST00000924584, ENST00000924585, ENST00000959251, ENST00000959252, ENST00000959253, ENST00000979787, ENST00000979788, ENST00001039312, ENST00001039313, ENST00001039314, ENST00001039316, ENST00001039317, ENST00001039319, ENST00001039320, ENST00001102867, ENST00001105726, ENST00001116222, ENST00001121771, ENST00001123981, ENST00001128748, ENST00001141597
RefSeq mRNA: 2 — MANE Select: NM_080667
NM_001282761, NM_080667
CCDS: CCDS1854, CCDS62911
Canonical transcript exons
ENST00000349456 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070505 | 55544220 | 55544369 |
| ENSE00001070509 | 55528878 | 55528992 |
| ENSE00001146757 | 55522102 | 55522166 |
| ENSE00001739672 | 55523721 | 55523822 |
| ENSE00001880981 | 55519718 | 55519916 |
| ENSE00001913381 | 55544907 | 55545079 |
| ENSE00003490464 | 55535712 | 55535763 |
| ENSE00003578022 | 55543938 | 55544074 |
| ENSE00003613074 | 55533873 | 55533960 |
| ENSE00003670125 | 55537483 | 55537585 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 98.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 49.6260 / max 1062.1675, expressed in 1821 samples.
Highest expression (Bgee): testis, adenohypophysis, pituitary gland, uterine tube, calcaneal tendon.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP36 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 14 tissues and its splicing (sQTL) in 6 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
20 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Adipose Subcutaneous | eqtl | 3.7e-09 | -0.17 | 2:55566340:G:A |
| Lung | sqtl | 4.3e-08 | +0.50 | 2:55568421:C:T |
| Brain Cortex | sqtl | 1.4e-06 | +0.95 | 2:55440271:C:T |
| Nerve Tibial | eqtl | 2.2e-05 | -0.16 | 2:55569702:G:A |
| Breast Mammary Tissue | eqtl | 4.2e-05 | -0.16 | 2:55541747:G:T |
| Brain Cerebellum | eqtl | 6.7e-05 | +0.82 | 2:55459248:G:C |
| Brain Cortex | eqtl | 1.6e-03 | -0.13 | 2:55558388:A:T |
| Brain Hypothalamus | sqtl | 2.0e-03 | +0.72 | 2:55441868:T:A |
| Esophagus Mucosa | eqtl | 2.1e-03 | -0.15 | 2:55551753:A:AAAAT |
| Brain Cerebellar Hemisphere | eqtl | 9.3e-03 | +0.48 | 2:55699746:C:G |
| Lung | eqtl | 1.1e-02 | -0.12 | 2:55562278:T:C |
| Adipose Visceral Omentum | eqtl | 1.1e-02 | -0.10 | 2:55562278:T:C |
| Brain Nucleus accumbens basal ganglia | eqtl | 1.7e-02 | -0.13 | 2:55571801:G:T |
| Cells Cultured fibroblasts | eqtl | 1.7e-02 | -0.14 | 2:55008830:T:C |
| Brain Cerebellum | sqtl | 1.9e-02 | +0.50 | 2:55716611:C:T |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.2e-02 | -0.10 | 2:55579148:T:G |
| Adipose Subcutaneous | sqtl | 2.8e-02 | +0.57 | 2:55486142:A:G |
| Artery Tibial | eqtl | 3.1e-02 | -0.11 | 2:55446815:T:C |
| Brain Frontal Cortex BA9 | sqtl | 3.7e-02 | -2.12 | 2:55795703:G:A |
| Minor Salivary Gland | eqtl | 4.4e-02 | -0.75 | 2:54593746:C:A |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20343 | 47.9097 | 1821 |
| 20342 | 1.7163 | 1078 |
Top tissues by expression
showing 100 of 256 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.67 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.60 | gold quality |
| pituitary gland | UBERON:0000007 | 98.50 | gold quality |
| right testis | UBERON:0004534 | 98.46 | gold quality |
| right uterine tube | UBERON:0001302 | 97.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 97.75 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.74 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.69 | gold quality |
| hypothalamus | UBERON:0001898 | 97.68 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.52 | gold quality |
| testis | UBERON:0000473 | 97.49 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.36 | gold quality |
| putamen | UBERON:0001874 | 97.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.27 | gold quality |
| amygdala | UBERON:0001876 | 97.13 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.99 | gold quality |
| left ovary | UBERON:0002119 | 96.85 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.80 | gold quality |
| pons | UBERON:0000988 | 96.79 | gold quality |
| bronchial epithelial cell | CL:0002328 | 96.75 | gold quality |
| right ovary | UBERON:0002118 | 96.59 | gold quality |
| neocortex | UBERON:0001950 | 96.52 | gold quality |
| thyroid gland | UBERON:0002046 | 96.51 | gold quality |
| frontal cortex | UBERON:0001870 | 96.48 | gold quality |
| bronchus | UBERON:0002185 | 96.42 | gold quality |
| forebrain | UBERON:0001890 | 96.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.38 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.36 | gold quality |
| endocervix | UBERON:0000458 | 96.32 | gold quality |
| body of uterus | UBERON:0009853 | 96.32 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 96.31 | gold quality |
| lower esophagus | UBERON:0013473 | 96.28 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.16 | gold quality |
| tendon | UBERON:0000043 | 96.09 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.00 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.99 | gold quality |
| cerebral cortex | UBERON:0000956 | 95.93 | gold quality |
| tibial nerve | UBERON:0001323 | 95.93 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.93 | gold quality |
| brain | UBERON:0000955 | 95.92 | gold quality |
| cortical plate | UBERON:0005343 | 95.92 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 95.85 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 95.84 | gold quality |
| substantia nigra | UBERON:0002038 | 95.78 | gold quality |
| left coronary artery | UBERON:0001626 | 95.76 | gold quality |
| tibial artery | UBERON:0007610 | 95.73 | gold quality |
| popliteal artery | UBERON:0002250 | 95.71 | gold quality |
| ovary | UBERON:0000992 | 95.70 | gold quality |
| right coronary artery | UBERON:0001625 | 95.66 | gold quality |
| ventricular zone | UBERON:0003053 | 95.57 | gold quality |
| left uterine tube | UBERON:0001303 | 95.56 | gold quality |
| sural nerve | UBERON:0015488 | 95.50 | gold quality |
| aorta | UBERON:0000947 | 95.46 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.45 | gold quality |
| midbrain | UBERON:0001891 | 95.39 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 95.36 | gold quality |
| gall bladder | UBERON:0002110 | 95.35 | gold quality |
| coronary artery | UBERON:0001621 | 95.33 | gold quality |
| ascending aorta | UBERON:0001496 | 95.26 | gold quality |
| thoracic aorta | UBERON:0001515 | 95.24 | gold quality |
| Ammon’s horn | UBERON:0001954 | 95.22 | gold quality |
| spinal cord | UBERON:0002240 | 95.19 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 95.09 | gold quality |
| pancreas | UBERON:0001264 | 94.98 | gold quality |
| body of pancreas | UBERON:0001150 | 94.83 | gold quality |
| fallopian tube | UBERON:0003889 | 94.81 | gold quality |
| right lung | UBERON:0002167 | 94.60 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 94.51 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.51 | gold quality |
| body of stomach | UBERON:0001161 | 94.50 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 94.49 | gold quality |
| cerebellar cortex | UBERON:0002129 | 94.40 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.35 | gold quality |
| temporal lobe | UBERON:0001871 | 94.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 94.24 | gold quality |
| ectocervix | UBERON:0012249 | 94.17 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 94.05 | gold quality |
| myometrium | UBERON:0001296 | 94.02 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 94.00 | gold quality |
| prostate gland | UBERON:0002367 | 93.96 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.94 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.89 | gold quality |
| peritoneum | UBERON:0002358 | 93.89 | gold quality |
| omental fat pad | UBERON:0010414 | 93.89 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.78 | gold quality |
| cortex of kidney | UBERON:0001225 | 93.72 | gold quality |
| cerebellum | UBERON:0002037 | 93.70 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 93.69 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.64 | gold quality |
| postcentral gyrus | UBERON:0002581 | 93.62 | gold quality |
| parietal lobe | UBERON:0001872 | 93.57 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.54 | gold quality |
| stomach | UBERON:0000945 | 93.54 | gold quality |
| uterus | UBERON:0000995 | 93.51 | gold quality |
| uterine cervix | UBERON:0000002 | 93.49 | gold quality |
| cartilage tissue | UBERON:0002418 | 93.40 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.35 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 28.72 |
| E-ANND-3 | yes | 11.81 |
| E-MTAB-9388 | yes | 7.03 |
| E-MTAB-10137 | yes | 4.11 |
| E-CURD-112 | no | 2.84 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 135.7 | high |
| Retina | tissue | 115.1 | |
| Pituitary gland | tissue | 113.7 | |
| Caudate putamen | tissue | 92.0 | |
| Frontal cortex | tissue | 91.5 | |
| Choroid plexus | tissue | 89.9 | |
| Postcentral gyrus | tissue | 79.5 | |
| Parathyroid gland | tissue | 73.3 | low |
| Thyroid gland | tissue | 72.9 | medium |
| Epididymis | tissue | 72.7 | medium |
| Nucleus accumbens | tissue | 66.7 | |
| Kidney | tissue | 59.0 | medium |
| Fallopian tube | tissue | 58.6 | medium |
| Locus coeruleus | tissue | 57.2 | |
| Ovary | tissue | 56.0 | medium |
| Hippocampus | tissue | 54.2 | low |
| Breast | tissue | 45.8 | medium |
| Endometrium 1 | tissue | 44.1 | low |
| Seminal vesicle | tissue | 42.3 | low |
| Cervix | tissue | 40.3 | medium |
| Adrenal gland | tissue | 40.3 | low |
| Prostate | tissue | 39.0 | low |
| Gallbladder | tissue | 38.3 | medium |
| Vagina | tissue | 35.9 | low |
| Smooth muscle | tissue | 34.9 | low |
| Cerebral cortex | tissue | 31.6 | medium |
| Occipital cortex | tissue | 31.6 | |
| Stomach 1 | tissue | 31.5 | medium |
| Urinary bladder | tissue | 31.1 | low |
| Somatosensory cortex | tissue | 31.1 | |
| Prefrontal cortex | tissue | 29.7 | |
| Pancreas | tissue | 29.5 | medium |
| Putamen | tissue | 29.1 | |
| Heart muscle | tissue | 29.0 | low |
| Hippocampal formation | tissue | 28.9 | |
| Retrosplenial and cingulate cortex | tissue | 28.4 | |
| Motor cortex | tissue | 28.3 | |
| Lung | tissue | 28.0 | high |
| Entorhinal cortex | tissue | 27.7 | |
| Temporal cortex | tissue | 27.4 | |
| Olfactory bulb | tissue | 26.3 | |
| Basal ganglia | tissue | 26.2 | low |
| Retrosplenial cortex | tissue | 25.7 | |
| Tongue | tissue | 25.3 | |
| Septum | tissue | 25.3 | |
| Ventral forebrain | tissue | 24.2 | |
| Pons | tissue | 24.1 | |
| Adipose tissue | tissue | 23.9 | low |
| Insular cortex | tissue | 23.7 | |
| Cerebellum | tissue | 23.6 | low |
| Thalamus | tissue | 23.2 | |
| Superior colliculi | tissue | 22.6 | |
| Amygdala | tissue | 22.5 | |
| Rectum | tissue | 21.7 | medium |
| Thymus | tissue | 21.3 | |
| Midbrain | tissue | 21.0 | |
| Hypothalamus | tissue | 21.0 | |
| Esophagus | tissue | 20.5 | low |
| Lymph node | tissue | 20.3 | low |
| Colon | tissue | 20.3 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Arcuate nucleus (80.3), Premotor cortex, ventral (71.8), Perirhinal gyrus (71.4), Olfactory tubercle (70.6), Nucleus of the diagonal band (70.3).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 0.0141, LOEUF 0.867, missense Z -0.504 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000349456 — one region, missense o/e 1.03.
Literature-anchored findings (GeneRIF, showing 1)
- The association between Yo and CCDC104 antibodies in paraneoplastic neurological syndromes may indicate functional similarities. (PMID:19680650)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap36 | ENSDARG00000037079 |
| mus_musculus | Cfap36 | ENSMUSG00000020462 |
| rattus_norvegicus | Cfap36 | ENSRNOG00000003901 |
| drosophila_melanogaster | CG14367 | FBGN0038170 |
| caenorhabditis_elegans | WBGENE00022435 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1913994) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 3 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| decreased body weight | 1 |
| decreased circulating alkaline phosphatase level | 1 |
| increased circulating sodium level | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q32PC9 | 98.8% | Diamond |
| Xenopus tropicalis | Q28IH8 | 85.8% | Diamond |
| Xenopus laevis | Q7T0S7 | 85.8% | Diamond |
| Gallus gallus | Q5ZKW5 | 80.3% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| PPP4R3B | protein-coding | 57223 |
| PNPT1 | protein-coding | 87178 |
| PPP4R3B-DT | ncRNA | 107985885 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 36 — Q96G28 (reviewed: Q96G28)
Alternative names: Coiled-coil domain-containing protein 104
All UniProt accessions (4): B5MC35, B5MCA1, B5MD16, Q96G28
UniProt curated annotations — full annotation on UniProt →
Function. May act as an effector for ARL3.
Subunit / interactions. Interacts with ARL3.
Subcellular location. Nucleus. Cytoplasm. Cell projection. Cilium. Flagellum.
Tissue specificity. Expressed in several human tissues including brain, testis, heart, lung, pancreas and spleen (at protein level).
Similarity. Belongs to the CFAP36 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96G28-1 | 1 | yes |
| Q96G28-2 | 2 |
RefSeq proteins (2): NP_001269690, NP_542398* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR023379 | BART_dom | Domain |
| IPR038888 | CFAP36 | Family |
| IPR042541 | BART_sf | Homologous_superfamily |
Pfam: PF11527
UniProt features (15 total): region of interest 3, modified residue 3, sequence variant 3, compositionally biased region 3, chain 1, splice variant 1, coiled-coil region 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96G28-F1 | 73.92 | 0.35 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): nucleoplasm; cytosol; nuclear bodies; nucleoli fibrillar center; primary cilium
Antibody reliability (HPA): IH approved · IF approved
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3)
| Type | Positions |
|---|---|
| Phosphoserine | 201, 85, 147 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 62 (showing top):
CCAWYNNGAAR_UNKNOWN, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CILIARY_TRANSITION_ZONE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_CILIARY_BASE, WGTTNNNNNAAA_UNKNOWN, GOCC_CILIUM, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, HAMAI_APOPTOSIS_VIA_TRAIL_UP, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ZNF585B_TARGET_GENES, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): nucleus (GO:0005634), axoneme (GO:0005930), motile cilium (GO:0031514), ciliary transition zone (GO:0035869), ciliary base (GO:0097546), cytoplasm (GO:0005737), cilium (GO:0005929)
GO top-level categories
13 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cilium | 3 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| ciliary transition zone | 1 |
| ciliary transition fiber | 1 |
| intracellular anatomical structure | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 1 of 8 annotations. The rest are phylogenetic / computational / electronic (IEA).
1 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| ciliary transition zone | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 406 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP36 | ARL3 | P36405 | 643 |
| CFAP36 | FAM161B | Q96MY7 | 549 |
| CFAP36 | FAM81B | Q96LP2 | 526 |
| CFAP36 | ZCCHC17 | Q9NP64 | 525 |
| CFAP36 | TTC29 | Q8NA56 | 522 |
| CFAP36 | CCDC63 | Q8NA47 | 505 |
| CFAP36 | IWS1 | Q96ST2 | 478 |
| CFAP36 | CNOT10 | Q9H9A5 | 477 |
| CFAP36 | RIBC2 | Q9H4K1 | 472 |
| CFAP36 | SPICE1 | Q8N0Z3 | 450 |
| CFAP36 | MKS1 | Q9NXB0 | 448 |
| CFAP36 | VWA1 | Q6PCB0 | 432 |
| CFAP36 | DNAAF9 | Q5TEA3 | 409 |
| CFAP36 | ATP5PB | P24539 | 409 |
| CFAP36 | GAREM1 | Q9H706 | 402 |
IntAct
Human interaction partners of CFAP36 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
5 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| SNTB2 | association | 0.620 | 2 |
| DAZAP2 | physical association | 0.560 | 3 |
| ARL2 | association | 0.530 | 1 |
| FCHSD2 | physical association | 0.000 | 1 |
| RAC1 | physical association | 0.000 | 1 |
BioGRID (35 interactions; top human partners by supporting records): ARL2 (Affinity Capture-MS; 3 records), KCTD10 (Affinity Capture-MS; 2 records), OSBPL9 (Affinity Capture-MS; 2 records), SNTB2 (Affinity Capture-MS; 2 records), UBC (Reconstituted Complex; 2 records), ACBD5 (Proximity Label-MS), ARL3 (Proximity Label-MS), BDH2 (Affinity Capture-MS), BRPF3 (Affinity Capture-MS), COX8A (Proximity Label-MS), DPP9 (Proximity Label-MS), FAS (Proximity Label-MS), FCHSD2 (Two-hybrid), HSPA1A (Affinity Capture-MS), MFN2 (Proximity Label-MS)
Disease & clinical
Genetic variants
Variant evidence for CFAP36: 65 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 32 predictions of 874):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 2:55519917–55519918 | donor_loss | 1.0000 | 5 |
| 2:55522095–55522097 | acceptor_gain | 1.0000 | 2 |
| 2:55522100 | acceptor_loss | 1.0000 | 3 |
| 2:55522167 | donor_loss | 1.0000 | 2 |
| 2:55523719–55523720 | acceptor_loss | 1.0000 | 4 |
| 2:55523822–55523824 | donor_loss | 1.0000 | 6 |
| 2:55529015 | donor_gain | 1.0000 | |
| 2:55533871–55533872 | acceptor_loss | 1.0000 | 6 |
| 2:55533950 | donor_gain | 1.0000 | |
| 2:55533961–55533962 | donor_loss | 1.0000 | 2 |
AlphaMissense
630 missense substitutions predicted likely pathogenic (of 2,278 scored), across 164 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M113 | 9 | 0.966 | 0.997 |
| F40 | 8 | 0.992 | 0.999 |
| F109 | 8 | 0.990 | 0.999 |
| N117 | 8 | 0.979 | 0.993 |
| F32 | 8 | 0.955 | 0.997 |
| F79 | 8 | 0.936 | 0.998 |
| D41 | 8 | 0.882 | 0.963 |
| W25 | 7 | 0.991 | 0.999 |
| F106 | 7 | 0.988 | 0.998 |
| F19 | 7 | 0.976 | 0.996 |
| H54 | 7 | 0.969 | 0.998 |
| W11 | 7 | 0.963 | 0.997 |
| E45 | 7 | 0.957 | 0.979 |
| D105 | 7 | 0.954 | 0.973 |
| C37 | 7 | 0.923 | 0.996 |
| R328 | 7 | 0.912 | 0.995 |
| E153 | 7 | 0.895 | 0.959 |
| E338 | 7 | 0.895 | 0.943 |
| E34 | 7 | 0.855 | 0.971 |
| M120 | 7 | 0.846 | 0.961 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 0.000219 |
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010002_46 | Refractive error | 3e-34 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression | 3 |
| Cyclosporine | increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| K 7174 | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.